Back to
LAZARD ASSET MANAGEMENT LLC
CRNX2 quarters
Position history for
LAZARD ASSET MANAGEMENT LLC's holdings in CRINETICS PHARMACEUTICALS IN
LAZARD ASSET MANAGEMENT LLC previously held 0 shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $0 as of 2022-Q2.
Final Value
$0
Final Shares
0
Total Value Change
-$408,000
Total Shares Change
-18,612
Quarter-by-Quarter History
Other major holders of CRNX: FMR LLC